Clinical trial
Impact of Irbesartan on Oxidative Stress and C-Reactive Protein Levels in Patients With Persistent Atrial Fibrillation
NCT00613496 is registered in ClinicalTrials.gov with University of Magdeburg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Irbesartan on Oxidative Stress and C-Reactive Protein Levels in Patients With Persistent Atrial Fibrillation
- Lead sponsor
- University of Magdeburg
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- May 31, 2009
- Completion date
- May 31, 2010
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
persistent atrial fibrillation
Lead sponsor's other trials
University of Magdeburg, most recent start first.
+29 more trials See the organization page
Similar trials
Same condition (Atrial Fibrillation) and phase, most recent start first.
+340 more trials See the condition page